A new chapter in lipid signaling and kidney fibrosis.

Published in: Science translational medicine (2022)

The perivascular sphingosine 1-phosphate signaling axis may be an emerging therapeutic target for treating chronic kidney disease (Tanaka et al. ).

Keyphrases